An article about the B Pharma course, its eligibility, fees, salary & the future prospects after doing the course.
The course of B Pharma is one of the most sought after course because it opens the gate for a flourishing career in Pharmacy.
Pharmacy is an evergreen domain because with frequent man animal conflict & climate change, more viruses are predicted to afflict humanity.
The B Pharma course is evergreen because the need for human involvement limits the influence of Artificial Intelligence on healthcare in researching and developing potential medicines.
In such testing times, the B Pharma course is your ideal Launchpad for a high-flying career in the domain of pharmacy.
The pharmaceutical industry in India is projected to experience substantial growth in the upcoming years, with some estimates showing it could reach $450 billion by 2047.
The Indian pharmaceutical industry doesn’t just meet domestic demand; it also controls over 20% of the global pharmaceutical supply chain and caters to around 60% of the global vaccine demand.
The above figures paint a positive picture of the B Pharma course because it launches one’s career in a promising & export-oriented sector.
Candidates must have passed the 10+2 examination with English as one subject and Physics, Chemistry, and Mathematics (PCM) or Biology (PCB/PCMB)
Candidates must have completed a diploma in Pharmacy from an institution approved by the Pharmacy Council of India under section 12 of the Pharmacy Act
The eligibility clarifies that both Mathematics & Biology students can pursue Pharmacy as both PCM & PCB are eligible for the course.
India has a sizeable population having hypertension & diabetes that makes it an ideal destination for advanced pharmaceutical research.
11.4% of Indians have diabetes while 35.5% have high blood pressure susceptible to various drugs that help to control the disease.
The B Pharma course in India is ideal because India has the unfortunate record of having the highest number of deaths because of high blood pressure, with approximately 1.54 million fatalities.
In comparison, air pollution caused 1.24 million deaths in India.
Further high blood sugar level led to 1 million deaths in India, which signifies unhealthy eating habits of Indians. In 2017, smoking was a common factor in the deaths of 894,372 Indian residents.
The figures underscore that the B Pharma course is focused on job opportunities since companies engage in research to develop affordable and effective innovative drugs. India is the largest producer of generic medicines in the world, contributing 20% to the global market by volume.
After knowing the B Pharma eligibility, candidates should know the B Pharma fees at government institutions in UP.
| Institution Name | B Pharma Course fees (Approximate) |
| Bundelkhand University Jhansi | 3 L |
| IMS BHU Varanasi | 54.03 K |
| SHUATS Allahabad | 5.60L |
| UPUMS Safai | 62K |
| VBSPU Jaunpur | 2.40L |
| MJPRU Bareilly | 3.01 L |
| CSJMU Kanpur | 2.85 L |
| Prof. Rajendra Singh University Prayagraj | 3.91 L |
The B Pharma fees at some of the other Government institutions in the country are:
| College Name | Location | B Pharm Fees (approximate) |
| Delhi Institute of Pharmaceutical Sciences and Research | New Delhi | INR 35,350 |
| ICT Mumbai | Mumbai | INR 341,400 |
| Government College of Pharmacy, Amravati | Maharashtra | INR 97,500 |
| Pharmacy College, Saifai | Uttar Pradesh | INR 86,200 |
| Jadavpur University | Kolkata | INR 9,600 |
| Madras Medical College, Chennai | Chennai | INR 646,000 |
| School of Pharmacy Devi Ahilya Vishwavidyalaya, Indore | Madhya Pradesh | INR 325,344 |
| University Institute of Pharmaceutical Sciences | Chandigarh | INR 58,660 |
| Madurai Medical College | Tamil Nadu | INR 320,000 |
| Annamalai University | Tamil Nadu | INR 145,520 |
| Dibrugarh University | Assam | INR 23,280 |
For detailed information about B Pharma fees at private colleges, please refer to the following link: https://venkateshwaragroup.in/vgiblog/blog/b-pharma-eligibility/
Pharmacists are indispensable for health because they dispense medicines as prescribed by the Doctor.
Without the pharmacist making the drug available, doctors would find it difficult to cure the patient.
In fact, pharmacists are the vital link between the Doctor & patient because they dispense drugs & explain drug regimen to the patient.
Pharmacists supplement healthcare because they are qualified to dispense medicines and make OTC medicines available for use.
During the Corona induced lockdown, pharmacists supported healthcare by making the medicines available because they operated during the lockdown.
The increased human interaction with wild animals is causing more zoonotic viruses to jump species & affect humans.
The shrinking forest cover is leading to wild animals encroaching on human habitation and coming into contact with humans.
This is the primary reason more zoonotic viruses will afflict humanity, the latest being MPox, India has already reported its first case.
Such developments present tremendous opportunities for pharma researchers who can develop potent vaccines to protect humanity.
One such development is the innovation of the TB vaccine that will be a fundamental change for TB patients.
MTBVAC, developed by Biofabri in collaboration with Hyderabad-based Bharat Biotech, is derived from a human strain of the Mycobacterium tuberculosis bacteria.
It will be a more effective and enduring substitute for the BCG vaccine, which is currently the only tuberculosis (TB) vaccine available.
The salary after doing B Pharma is decent & increases with experience & skill development. For a detailed overview on the course of B pharma & its salary, please visit the following link:
Pharmacy is an evergreen field because with enhanced human wildlife interaction, more viruses will afflict humanity.
Therefore, pharmacists conduct research to develop effective medicines that will protect us from deadly viruses.
Further with ageing population & fewer births, many countries have tasked scientists to develop anti-ageing products that will enhance the working age of its population.
Mumbai based Entod pharmaceuticals has received approval from DCGI (Drug Controller General of India) for its PresVu eye drops that claim to improve vision for those suffering from Presbyopia.
Presbyopia affects people over 40 who find it difficult to read naked eyes & have to take the help of spectacles for a clearer view.
It’s an innovative medicine for billions of people suffering from Presbyopia who depend on eye lenses/spectacles to a clear vision.
The company plans to export the product as approximately 1.8 billion people suffer from Presbyopia globally.
Shri Venkateshwara University/Institute, in partnership with the Women Welfare Department of the UP Government, awarded… Read More
The tentative last date for BBA admission 2025 could be the 3rd week of October… Read More
Shri Venkateshwara University organized an All India Kavi Sammelan & Bollywood Musical Night on the… Read More
A B.Tech degree in civil engineering prepares you for roles in designing, planning, organizing, building,… Read More
Shri Venkateshwara University/Institute launched a Mega Cleanliness drive on the major bank of the river… Read More
BCA Admission 2025: The application process for the Bachelor of Computer Applications (BCA) program for… Read More